The Trump Administration now requires drug advertising to provide a medication's list price. Manufacturers that were initially resistant have reconsidered and have agreed. The only group losing here are patients, who are no closer to lower drug prices or better information than before.
For all the regulation of what's written in direct-to-consumer health ads (and for all the hand-wringing about informed consent), there's little said about what patients understand. As it turns out, health literacy is a problem. And those with the biggest problems are looking for help in all the wrong places.